0001691421-20-000014.txt : 20201117
0001691421-20-000014.hdr.sgml : 20201117
20201117173052
ACCESSION NUMBER: 0001691421-20-000014
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201104
FILED AS OF DATE: 20201117
DATE AS OF CHANGE: 20201117
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Espinel Jorge
CENTRAL INDEX KEY: 0001816039
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39367
FILM NUMBER: 201322163
MAIL ADDRESS:
STREET 1: C/O LEMONADE, INC.
STREET 2: 5 CROSBY STREET, 3RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10013
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Lemonade, Inc.
CENTRAL INDEX KEY: 0001691421
STANDARD INDUSTRIAL CLASSIFICATION: FIRE, MARINE & CASUALTY INSURANCE [6331]
IRS NUMBER: 320469673
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5 CROSBY STREET
STREET 2: 3RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10013
BUSINESS PHONE: 9176089499
MAIL ADDRESS:
STREET 1: 5 CROSBY STREET
STREET 2: 3RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10013
4
1
wf-form4_160565223674208.xml
FORM 4
X0306
4
2020-11-04
0
0001691421
Lemonade, Inc.
LMND
0001816039
Espinel Jorge
C/O LEMONADE, INC.
5 CROSBY STREET, 3RD FLOOR
NEW YORK
NY
10013
0
1
0
0
CBDO
COMMON STOCK
2020-11-13
4
M
0
20000
5.26
A
20000
D
COMMON STOCK
2020-11-13
4
S
0
3081
56.0427
D
16919
D
COMMON STOCK
2020-11-13
4
S
0
9915
57.0934
D
7004
D
COMMON STOCK
2020-11-13
4
S
0
3200
58.0658
D
3804
D
COMMON STOCK
2020-11-13
4
S
0
1900
59.3368
D
1904
D
COMMON STOCK
2020-11-13
4
S
0
1904
59.8987
D
0
D
STOCK OPTION
59.7
2020-11-04
4
A
0
50000
0
A
2030-11-03
COMMON STOCK
50000.0
50000
D
STOCK OPTION
5.26
2020-11-13
4
M
0
20000
0
D
2028-10-06
COMMON STOCK
20000.0
330000
D
Represents sale pursuant to a Rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.54 to $56.47. The reporting person undertakes to provide Lemonade, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.58 to $57.56 The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.61 to $58.595. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.625 to $59.575. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.785 to $60.08. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The option will vest and become exercisable as to 25% on November 4, 2022, and in 12 equal quarterly installments thereafter beginning on February 4, 2023.
The option is vested and exercisable as to 175,000 shares, and the remaining shares will vest and become exercisable in eight quarterly installments beginning on January 1, 2021.
/s/ Timothy Bixby, Attorney-in-Fact for Jorge Espinel
2020-11-17